These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6287389)

  • 1. [Statistical regression analysis for four new cephalosporins (author's transl)].
    Sirot D; Glanddier Y; Chanal M; Sirot J; Cluzel R
    Pathol Biol (Paris); 1982 Jun; 30(6):357-62. PubMed ID: 6287389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
    Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
    Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Moxalactam and cefotaxime--two new beta-lactam antibiotics compared with three well-known cephalosporins].
    Baumgärtner M; Dickgiesser N; Müller S; Wundt W
    Arzneimittelforschung; 1981; 31(10):1677-81. PubMed ID: 6274361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of antimicrobial activity and stability to beta-lactamases of cefoperazone, cefotaxime, lamoxactam and ceftriaxon].
    Baumgärtner M; Grehn M; Wundt W
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):208-21. PubMed ID: 6289564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bacteriological in vitro studies with a new cephalosporin: cefotiam (author's transl)].
    Grimm H
    Arzneimittelforschung; 1981; 31(11):1867-9. PubMed ID: 6274364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of the new cephalosporin antibiotics cefotaxime, cefoperazone and lamoxactam].
    Pulverer G; Peters G
    Med Welt; 1982 Apr; 33(17):642-4. PubMed ID: 6285119
    [No Abstract]   [Full Text] [Related]  

  • 7. [In vitro activity of the oxa-beta-lactam LY 127935 against Bacteroides fragilis and other anaerobic gram-negative rods (author's transl)].
    Werner H; Krasemann C
    Infection; 1980; 8 Suppl 3():S 342-6. PubMed ID: 6447673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of bacterial pathogens to cefotetan judged by MIC and disc tests.
    Grimm H
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():37-43. PubMed ID: 6573324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression analyses for cefoperazone on Mueller-Hinton agar and DST agar.
    Langmaack H; Daschner F
    Clin Ther; 1980; 3(Spec Issue):123-6. PubMed ID: 6446384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of antibiotic disk charge on concordance curve of cefotaxime ].
    Drugeon HB; Seon M; Reynaud A; Chung SS; Courtieu AL
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):517-21. PubMed ID: 6289229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of moxalactam and cefoperazone against Streptococcus pneumoniae with differing susceptibilities to penicillin.
    Tarpay MM; Welch DF; Marks MI
    Chemotherapy; 1982; 28(4):261-6. PubMed ID: 6214382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of the in vitro activity of new cephalosporins on strains of Neisseria gonorrhoeae of the Toulouse region.
    Prère MF; Lefèvre JC; Lareng MB
    Chemotherapy; 1981; 27 Suppl 1():15-8. PubMed ID: 6265158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro bacteriostatic activity of cefmenoxime (SCE 1365), cefotaxime and moxalactam].
    Husson MO; Bryskier A; Izard D; Leclerc H
    Pathol Biol (Paris); 1983 May; 31(5):347-50. PubMed ID: 6312395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences among moxalactam, cefoperazone, and cefotaxime in activity against multiple-antibiotic-resistant gram-negative bacteria.
    Preston DA
    Rev Infect Dis; 1982; 4 Suppl():S516-21. PubMed ID: 6296965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of mezlocillin and azlocillin with cephalosporin antibiotics: cefoxitin, cefoperazone, cefotaxime and moxalactam.
    Neu HC; Labthavikul P
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():101-6. PubMed ID: 6281229
    [No Abstract]   [Full Text] [Related]  

  • 16. Interpretation of susceptibility testing of ceftriaxone.
    Squires E; Cleeland R; Christenson J; Boehni E
    Am J Med; 1984 Oct; 77(4C):12-6. PubMed ID: 6093512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility of Clostridium difficile isolates to cefotaxime, moxalactam, and cefoperazone.
    Greenfield RA; Kurzynski TA; Craig WA
    Antimicrob Agents Chemother; 1982 May; 21(5):846-7. PubMed ID: 6285817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro antibacterial activity of eight third generation cephalosporins (author's transl)].
    Deforges L; Le Van Thoi J; Soussy CJ; Duval J
    Pathol Biol (Paris); 1982 Jun; 30(6):363-9. PubMed ID: 6810282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefoperazone: regression analysis, disk content, and disk susceptibility testing considerations.
    Wright DN; Welch DF; Saxon BA; Clark SJ; Matsen JM
    Antimicrob Agents Chemother; 1982 Sep; 22(3):493-8. PubMed ID: 6215895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inoculum size effect on the MIC of cefoperazone, moxalactam, cefotaxime, cefoxitin and cephalothin for 118 strains of Haemophilus influenzae including 'tolerant' micro-organisms.
    Simard P; Bergeron MG
    J Antimicrob Chemother; 1982 Nov; 10(5):397-402. PubMed ID: 6294044
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.